As of 11:33am ET
| -0.88 / -0.90%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 102.50, with a high estimate of 123.00 and a low estimate of 82.00. The median estimate represents a +5.89% increase from the last price of 96.80.
The current consensus among 4 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.